[
  {
    "ts": null,
    "headline": "Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks",
    "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Vertex Pharmaceuticals (NASDAQ:VRTX) and the rest of the therapeutics stocks fared in Q3.",
    "url": "https://finnhub.io/api/news?id=18bfda0135a2aa54d03b89eec3fd6cc064a0749018283b2ee59ddfa87c8c2ffa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768879876,
      "headline": "Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks",
      "id": 138186518,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Vertex Pharmaceuticals (NASDAQ:VRTX) and the rest of the therapeutics stocks fared in Q3.",
      "url": "https://finnhub.io/api/news?id=18bfda0135a2aa54d03b89eec3fd6cc064a0749018283b2ee59ddfa87c8c2ffa"
    }
  }
]